The first round of bidding for Takeda Pharmaceutical's majority stake in Wako Pure Chemicals closed this week, with a number of companies and private equity funds reportedly in the running.

Osaka-based Takeda Pharmaceutical is cleaning house at a brisk pace as it moves to focus on core therapeutic areas with the latest move a possible sale of a majority stake in Wako Pure Chemical to ...